
Nikita Sushentsev
@nikisushentsev
Research Fellow @EmmaCambridge & @radiology_UOC | PhD @CaiusCollege and @Gates_Cambridge | MD Sechenov University | Prostate cancer MRI, biology, and metabolism
ID: 1287448502449115136
26-07-2020 18:03:44
191 Tweet
208 Followers
231 Following

How can we better predict which men with #prostatecancer will get biochemical recurrence after surgery? Fab new work in PNASNews led by Nikita Sushentsev, Ferdia Gallagher, Tristan Barrett shows tumour lactate imaging could be up to the task. ☕📕Read: bit.ly/3T4ZyTp



New research published on Abdominal Radiology explores volume and T2 intensity in prostate seminal vesicle invasion. #ProstateCancer Tristan Barrett Nikita Sushentsev Iztok Caglic


Delighted to start my Visiting Fellowship of Exeter College, Oxford to work with Ian Mills and the wider Nuffield Department of Surgical Sciences team to complete the analysis of some exciting prostate cancer trial data. Watch this space!


🤝 Our Research Impact team met Ferdia Gallagher and Tristan Barrett at Department of Radiology, University of Cambridge to discuss innovative work using hyperpolarised MRI to find aggressive #prostatecancer 🔎 The team hope this technique could help identify high-risk active surveillance patients


The promised tweetorial - many thanks Dr Hayley Luxton and Greg James Halliwell for posting!

At the recent European Society of Urogenital Radiology Annual Meeting in Lisbon, Portugal 🇵🇹, the Top 3 Most Cited #EuropeanRadiology papers in the field of Urogenital Imaging were awarded. 🎉 Congratulations to the authors! Have a look at these award-winning papers below: 🥇 buff.ly/4eF1JEy


A good quality scan gives us the best possible chance of spotting prostate cancer. That's why we're funding Dr Tristan Barrett at Cambridge University who is using AI to improve MRI scans nationwide. Your support will help unlock these answers. ➡️ Donate now: bit.ly/4eTWmkU

Thank you CRUK Cambridge Centre for highlighting our research! Great team effort by Department of Radiology, University of Cambridge and AstraZenecaUK to bring innovation to the clinic and help patients with prostate cancer get the most accurate diagnosis and choose appropriate management.


Thank you ProstateUK Profs for highlighting our work! 🙏


Thanks Tyler Seibert MD PhD for the great summary of our paper! Agree with Matt Cooperberg that adverse histology is 🗝️. More evidence soon, but time to move on from “any ≥GG2” to “adverse histology” Dx. Most current imaging/biomarkers were not intentionally built for this, but may adapt 🎯